| 1 | 08:00-08:10 |
Opening Remarks |
|
||||||||
| 1 | 08:10-08:20 |
Clinical Value of the Exosomal m6A-F-MDSC Activation Index in Predicting Urosepsis-Associated Acute Kidney Injury |
|
||||||||||||||
| 2 | 08:20-08:30 |
Application of Individualized Fluid Resuscitation in the Management of Postoperative Urosepsis Following Upper Urinary Tract Stone Surgery |
|
||||||||||||||
| 3 | 08:30-08:40 |
Microbial Flora, Drug Resistance Genes and Virulence Factors in Urinary Tract Infection Associated with Infection Stones |
|
||||||||||||||
| 4 | 08:40-08:50 |
- |
|
||||||||||||||
| 5 | 08:50-09:05 |
Discussion |
|
||||||||||||||
| 1 | 09:05-09:15 |
Management of Refractory Fungal Infection After Flexible Ureteroscopic Lithotripsy for Renal Stones |
|
||||||||||||||
| 2 | 09:15-09:25 |
Distribution and Drug Resistance of Pathogens in Urine Cultures from Urological Patients: A Three-Year Single-Center Analysis |
|
||||||||||||||
| 3 | 09:25-09:35 |
A Comparative Analysis of Metabolic and Urinary Bacterial Culture Profiles in Patients with Staghorn versus Non-Staghorn Infectious Renal Stones |
|
||||||||||||||
| 4 | 09:35-09:45 |
Mechanism of Geniposide in Alleviating Calcium Oxalate Stone Formation by Blocking Escherichia coli Fimbria-Renal Tubular Epithelial Receptor Adhesion and Activating the PPARγ Pathway |
|
||||||||||||||
| 5 | 09:45-10:00 |
Discussion |
|
||||||||||||||
| 1 | 10:00-10:10 |
Application of Desmodium styracifolium Total Flavonoid Capsules in Ureteral Stones |
|
||||||||||||||
| 2 | 10:10-10:20 |
Minimally Invasive Treatment Strategies for Upper Urinary Tract Stones Complicated with |
|
||||||||||||||
| 3 | 10:20-10:30 |
Exploration of Percutaneous Nephrolithotomy in the Minimally Invasive Treatment of Retroperitoneal Abscess: A Preliminary Study Based on 6 Clinical Cases |
|
||||||||||||||
| 4 | 10:30-10:40 |
Study on the diagnostic efficacy of the computerized tomography attenuation value of renal pelvis urine in true bacteriuria secondary to renal and ureteral stones |
|
||||||||||||||
| 5 | 10:40-10:55 |
Discussion |
|
||||||||||||||
| 1 | 10:55-11:05 |
From Three-Way Catheter to Modified Bladder Drainage: Outcome Analysis of Delayed Healing in a Case of Complicated Bladder Rupture with Alzheimer's Disease |
|
||||||||||||||
| 2 | 11:05-11:15 |
Research Progress in the Diagnosis and Treatment of Refractory Urinary Tract Infection Associated with Targeted Therapy and Immunotherapy |
|
||||||||||||||
| 3 | 11:15-11:25 |
Occult Fibrinogen Deficiency Diagnosed via Refractory Hematuria After Bilateral Upper Urinary Tract Stone Surgery: A Case Report |
|
||||||||||||||
| 4 | 11:25-11:35 |
Phased Results and Iterative Updates of the Survey Project on the Current Status and Perception of Uncomplicated Urinary Tract Infection Treatment in China |
|
||||||||||||||
| 5 | 11:35-11:50 |
Discussion |
|
||||||||||||||
| 1 | 11:50-12:05 |
Summary |
|
||||||||
| 1 | 13:30-13:40 |
Opening Remarks |
|
|||||
| 2 | 13:40-13:50 |
Discussion |
|
|||||
| 1 | 13:50-14:02 |
Robotic kidney transplantation -- The European experience |
|
||||||||||||||||||||||||||
| 2 | 14:02-14:10 |
Robot-Assisted Single-Port Laparoscopic Transplant Nephrectomy: Preliminary Experience and Technical Considerations (Report of Three Cases) |
|
||||||||||||||||||||||||||
| 3 | 14:10-14:18 |
Robot-Assisted Ureterovesical Reanastomosis for Ureteral Stricture After Kidney Transplantation: Preliminary Experience |
|
||||||||||||||||||||||||||
| 4 | 14:18-14:26 |
Applications of Robot-Assisted Kidney Transplantation in Special Clinical Scenarios and Management of Complex Cases |
|
||||||||||||||||||||||||||
| 5 | 14:26-14:34 |
Feasibility and Safety of Gene-Edited Porcine Red Blood Cells for Normothermic Machine Perfusion of Human Kidneys |
|
||||||||||||||||||||||||||
| 6 | 14:34-14:42 |
Discussion |
|
||||||||||||||||||||||||||
| 1 | 14:42-14:54 |
The Second Pig-to-Human Kidney Xenotransplantation in Asia and a Review of Our Center’s Experience in Kidney Xenotransplantation |
|
|||||||||||||||||||||||||||||
| 2 | 14:54-15:02 |
Eculizumab Combined with Daratumumab for Acute Antibody-Mediated Rejection After Kidney Transplantation: A Single-Center Experience |
|
|||||||||||||||||||||||||||||
| 3 | 15:02-15:10 |
Evaluation of Early Postoperative Outcomes and Prognostic Analysis in Pediatric Kidney Transplantation |
|
|||||||||||||||||||||||||||||
| 4 | 15:10-15:18 |
Early Clinical Experience with Bacteriophage Therapy for Multidrug-Resistant Bacterial Infections in Kidney Transplant Recipients: A Beacon of Hope in the Antimicrobial Resistance Crisis |
|
|||||||||||||||||||||||||||||
| 5 | 15:18-15:26 |
Discussion |
|
|||||||||||||||||||||||||||||
| 1 | 15:26-15:38 |
Renal Cell Carcinoma of the Transplanted Kidney: From Treatment to Origin |
|
||||||||||||||||||||||||||||||||
| 2 | 15:38-15:46 |
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Nondiabetic Kidney Transplant Recipients |
|
||||||||||||||||||||||||||||||||
| 3 | 15:46-15:54 |
Long-Term Single-Center Follow-Up of the Effects of Denosumab on Mineral and Bone Metabolism in Kidney Transplant Recipients |
|
||||||||||||||||||||||||||||||||
| 4 | 15:54-16:02 |
A prospective study to explore the impact of cardiovascular calcification on the poor prognosis of kidney transplant patients |
|
||||||||||||||||||||||||||||||||
| 5 | 16:02-16:10 |
Discussion |
|
||||||||||||||||||||||||||||||||
| 1 | 16:10-16:22 |
A dynamic model for predicting severe PJP in kidney transplant recipients that integrates machine learning and the timing of infection |
|
|||||||||||||||||||||||||||||
| 2 | 16:22-16:30 |
Multi-Omics and Nanodrug Delivery Study of SPP1 as an Early Predictive Biomarker and Therapeutic Target for Kidney Allograft Fibrosis |
|
|||||||||||||||||||||||||||||
| 3 | 16:30-16:38 |
Mechanisms by Which LRG1 Regulates GPR162/cGAS–STING-Mediated Mitochondrial Dysfunction and Promotes Neutrophil Extracellular Trap Formation in Acute Kidney Injury |
|
|||||||||||||||||||||||||||||
| 4 | 16:38-16:46 |
The Endoplasmic Reticulum Stress–Induced XBP1s–GAS1 Axis Activates Hedgehog Signaling to Promote Tertiary Lymphoid Structure Development After Transplantation of Kidneys from Older Donors |
|
|||||||||||||||||||||||||||||
| 5 | 16:46-16:54 |
Effects of Transitional Care Interventions on Self-Management and Medication Adherence After Discharge in Kidney Transplant Recipients |
|
|||||||||||||||||||||||||||||
| 6 | 16:54-17:02 |
Mechanisms by Which Leucine Metabolism Modulates NK Cell Subset Imbalance to Ameliorate Memory-Like Rejection Following Transplantation |
|
|||||||||||||||||||||||||||||
| 7 | 17:02-17:10 |
Discussion |
|
|||||||||||||||||||||||||||||
| 1 | 17:10-17:20 |
Summary of the Kidney Transplantation Session |
|
|||||